Clinical Chemistry - Substrates Portfolio

You can make our experience your advantage, helping diagnostics drive the future of healthcare to come.

cobas c packs
Achieve greater efficiency and accuracy in every detail, with benefits that reach far beyond the laboratory.

Substrates add crucial information for diagnosis, therapy, compliance and prediction. The comprehensive metabolic panel (CMP) includes eight substrates assays and is commonly ordered for a first checkup about the current status of kidneys, electrolyte and acid/base balance, as well as blood sugar.

Substrates are less expensive and available more quickly than special analytic tests1, that’s why they contribute added value to each clinical laboratory.

Roche offers the broadest Clinical Chemistry portfolio2 in the market and also maintains and invests in the current existing Clinical Chemistry tests as for example with Calcium Gen.2, which is patented and unique in the market.

Roche Clinical Chemistry analyzer - consolidation without compromise.


  • Albumin
  • Ammonia - NH3
  • Bicarbonate - CO2
  • Bilirubin direct - BILD
  • Bilirubin total - BILT
  • Blood Urea Nitrogen - UREA/BUN
  • Calcium - CA
  • Cholesterol
  • Creatinine Jaffé
  • Creatinine Enzymatic
  • Fructosamine
  • Glucose
  • HDL Cholesterol direct - HDL-C
  • Homocysteine
  • Iron
  • Lactate
  • LDL Cholesterol direct - LDL-C
  • Magnesium
  • Phosphorus
  • Total Protein - TP
  • Total Protein Urine / CSF - TPUC
  • Triglycerides
  • Unsaturated Iron-Binding Capacity - UIBC
  • Uric Acid - UA
  1. Data on file, Roche Diagnostics Finance tool (2022)
  2. Internal data. Package inserts available at Roche from the individual web pages (reviewed July 2022),,